Synergistic antimicrobial photodynamic therapy using gated mesoporous silica nanoparticles containing curcumin and polymyxin B.

Fecha de publicación: Fecha Ahead of Print:

Autores de IIS La Fe

Participantes ajenos a IIS La Fe

  • Medaglia, Serena
  • Otri, Ismael
  • Bernardos, Andrea
  • Marcos, Maria Dolores

Grupos

Abstract

Photodynamic Therapy is a therapy based on combining a non-toxic compound, known as photosensitizer (PS), and irradiation with light of the appropriate wavelength to excite the PS molecule. The photon absorption by the PS leads to reactive oxygen species generation and a subsequent oxidative burst that causes cell damage and death. In this work, we report an antimicrobial nanodevice that uses the activity of curcumin (Cur) as a PS for antimicrobial Photodynamic Therapy (aPDT), based on mesoporous silica nanoparticles in which the action of the classical antibiotic PMB is synergistically combined with the aPDT properties of curcumin to combat bacteria. The synergistic effect of the designed gated device in combination with irradiation with blue LED light (470?nm) is evaluated against Escherichia coli, Pseudomonas aeruginosa and Staphylococcus epidermidis. The results show that the nanodevice exhibits a noteworthy antibacterial activity against these microorganisms, a much more significant effect than free Cur and PMB at equivalent concentrations. Thus, 0.1?g/mL of MSNs-Cur-PMB eliminates a bacterial concentration of about 105 CFU/mL of E. coli, while 1?g/mL of MSNs-Cur-PMB is required for P. aeruginosa and S. epidermidis. In addition, antibiofilm activity against the selected bacteria was also tested. We found that 0.1?mg/mL of MSNs-Cur-PMB inhibited 99?% biofilm formation for E. coli, and 1?mg/mL of MSNs-Cur-PMB achieved 90?% and 100?% inhibition of biofilm formation for S. epidermidis and P. aeruginosa, respectively.

Copyright © 2024 The Authors. Published by Elsevier B.V. All rights reserved.

Datos de la publicación

ISSN/ISSNe:
0378-5173, 1873-3476

INTERNATIONAL JOURNAL OF PHARMACEUTICS  Elsevier BV

Tipo:
Article
Páginas:
123947-123947
PubMed:
38408553
Factor de Impacto:
1,000 SCImago
Cuartil:
Q1 SCImago

Documentos

  • No hay documentos

Métricas

Filiaciones

Filiaciones no disponibles

Keywords

  • Antimicrobial photodynamic therapy, Curcumin, Mesoporous silica nanoparticles, Polymyxin B

Campos de Estudio

Proyectos y Estudios Clínicos

NANOMATERIALES INTELIGENTES, SONDAS Y DISPOSITIVOS PARA EL DESARROLLO INTEGRADO DE NUEVAS HERRAMIENTAS APLICADAS AL CAMPO BIOMÉDICO

Investigador Principal: JUAN BAUTISTA SALOM SANVALERO

MAT2015-64139-C4-1-R . MINISTERIO DE ECONOMIA Y COMPETITIVIDAD . 2016

PROGRAMA TÉCNICO DE APOYO. MODALIDAD INFRAESTRUCTURA.

Investigador Principal: RAMÓN MARTÍNEZ MÁÑEZ

PTA2016-12603-1 . MINISTERIO DE ECONOMIA Y COMPETITIVIDAD . 2018

PLATAFORMA PARA LA DETECCIÓN DE PATÓGENOS BASADA EN MATERIALES CON PUERTAS MOLECULARES (PATH-GATE).

Investigador Principal: RAMÓN MARTÍNEZ MÁÑEZ

DTS18/00090 . INSTITUTO DE SALUD CARLOS III . 2019

Contrato i-PFIS Doctorados IIS - empresa en Ciencias y Tecnologías de la Salud.

Investigador Principal: FÉLIX SANCENÓN GALARZA

IFI19/00026 . INSTITUTO DE SALUD CARLOS III . 2020

Nuevas estrategias en la prevención, diagnóstico y tratamiento de las infecciones asociadas con la asistencia sanitaria (REDUCHAI).

Investigador Principal: MARÍA ÁNGELES TORMO MAS

PID2021-122875OB-I00 . MINISTERIO DE CIENCIA E INNOVACION . 2022

Detección de patología cardiovascular en sangre con puertas moleculares del microRNA-4732-3p: una herramienta innovadora. (ACRÓNIMO GATE-4732-3p)

Investigador Principal: PILAR SEPÚLVEDA SANCHIS

DTS23/00017 . INSTITUTO DE SALUD CARLOS III . 2024

NUEVOS SISTEMAS DE DIAGNÓSTICO Y TRATAMIENTO BASADOS EN QUÍMICA SUPRAMOLECULAR Y NANOTECNOLOGÍA

Investigador Principal: RAMÓN MARTÍNEZ MÁÑEZ

INVEST/2023/443 . CONSELLERIA DE INNOVACIÓN, UNIVERSIDADES, CIENCIA Y SOCIEDAD DIGITAL . 2023

Cita

Compartir